Admission respiratory status predicts mortality in COVID‐19

• DOI: 10.1111/irv.12869
• Publication Date: 2021-05-24T10:17:55Z
• Authors: Neal A. Chatterjee; Paul N. Jensen; Andrew W. Harris; Daniel D. Nguyen; Henry D. Huang; Richard K. Cheng; Jainy J. Savla; Timothy R. Larsen; Joanne Michelle D...; Jeanne M. Du‐Fay‐...; Rozenn N. Lemaitre; Barbara McKnight; Sina A. Gharib; Nona Sotoodehnia
• Keywords: 2019-20 coronavirus outbreak; Betacoronavirus; Pandemic

COVID-19 has significant case fatality. Glucocorticoids are the only treatment shown to improve survival, but among patients requiring supplemental oxygen. WHO advises seek medical care for "trouble breathing," hypoxemic frequently have no respiratory symptoms. Our cohort study of hospitalized shows that symptoms uncommon and not associated with mortality. By contrast, objective signs compromise-oxygen saturation rate-are markedly elevated findings support expanding guidelines include at-home assessment oxygen rate in order expedite life-saving treatments high-risk patients.